Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Ian B. Tks for reply yesterday, yes bought/ordered the extras was just wondering whether anyone knew when we might get news of any allocations. Will sit tight mate, cheers for reply. ATB
NEW photocopier ....... Only way is up :)) GLA
Everyone is busy re-organising the cyber office and putting up the new signs, fresh new start this week!! We have even got a brand new photocopier.
It was allot more quiet than this few weeks ago. The company is going through allot of changes,take time for people to see potential. Pretty busy the other day. Morning.
Lively little BB this !!!!!
Morning all, Sun shinning and were still alive, every thing else is a bonus.
He is the former CEO of DxS, an innovator in the field of personalised medicine, developing and manufacturing companion diagnostics. DxS was funded with £3.5M in 2001 and was sold to QIAGEN BV in 2009 for £85M. That's a massive return on investment.
Detection of Down syndrome by maternal plasma DNA testing will alter the way that prenatal diagnosis and screening is delivered in the UK, both in the NHS and the private sector. It will have significant implications for some existing services such that clinical biochemistry serum screening laboratories and cytogenetic and molecular genetics laboratories can expect a fall in the number of samples. Since women are already accessing these tests, all obstetricians should have knowledge of the counselling issues involved. In addition, major NHS health policy decisions are required. In time, this technology is likely to become the primary screen for chromosomal abnormalities in pregnancy. This will enhance the information available to pregnant women while greatly reducing the loss of uncomplicated pregnancies as a result of miscarriage caused by unnecessary invasive procedures http://www.rcog.org.uk/files/rcog-corp/SIP_15_04032014.pdf
No matter whats the situation in September or January, and it looks good, very good or interesting indeed, the SP will start to move well before that date. Applied for an additional 45000 OO shares, expect to get about 50% allocated.
Not speaking for Stephen but... As per SFUs previous post, Reynolds told him (and I'm paraphrasing) "It's his best deal yet"
SFU is still in here, HH has never been in as far as i know.
yes sharky007, QIAGEN equipment is first stage of the analysis workflow (DNA extraction), and so I would imagine that Premaitha have contacts within potential clients through them. http://www.premaitha.com/the-iona-test/workflow feel pretty confident with future for this new company. GL
multibagger here guys, read Dr Stephen Little previous deal: Stephen is a successful serial biotechnology entrepreneur. He is the former CEO of DxS, an innovator in the field of personalised medicine, developing and manufacturing companion diagnostics. DxS was funded with £3.5M in 2001 and was sold to QIAGEN BV in 2009 for £85M. DxS pioneered the use of molecular diagnostic tests such as KRAS and EGFR mutation analysis to predict the use of novel cancer therapies. In 2009, DxS was acquired by QIAGEN and Stephen became Vice President of Personalised Healthcare, responsible for developing companion diagnostic partnerships with the pharma industry. Prior to his leading role at DxS, Stephen worked for 20 years in various senior positions in the diagnostic divisions of Astra Zeneca and ICI. He holds a PhD from Heriot-Watt University in Edinburgh. http://www.premaitha.com/company/the-team/27-company/the-team/management-team-and-directors/63-dr-stephen-little-chief-executive-officer-director
apologies misread that , i take it you bought your entitlement and want to know if youve got the extras? dont think thats known as yet.
youve missed it, you had to buy them be last thursday.
All. I have probably missed it but has anyone had notification about the additional share requests? i have noticed that my allocation is now showing in my account but no additional ones. Do they distribute at a later date (after the vote etc)or are we just not getting any at all?
Midlandboy, unless they've posted otherwise, i'm sure they are still invested here, just waiting on news etc, same as all of us, but if you want to talk to any of them specifically, try the wsg bb.
thanks alpha. i know they have fingers (or hands) in lots of different pies but i thought they were very active in viy too. always goin on about topping up here and there and everywhere etc. could be wrong....usually am.....must be AIM sending me completely mad...nothing new there then eh? Any ideas who it might have been then...riddler?
Midlandboy, try wsg, they're part of the furniture there.
does any one know where all the long term contributors to this BB (SFU/HaroldH etc to name but two i think) have gone? can't see a recent post. they were always so active on this BB. would be interesting to get their views on developments.
With Srephen Little speaking, looks like an important set of people in Oxford, coming up 16 July. http://www.oxbridgebiotech.com/events/next-generation-sequencing-lets-get-personal/
Premaitha Health (NIPT) This will be the new EPIC for the current company. The name change should happen on Friday after voting on Thursday.
The highly qualified team of scientists and technicians at Premaitha are also currently undergoing IONA® Test development and design verification processes; target completion for this stage is by 30 September 2014. The clinical performance and commercialisation testing is then anticipated to be substantially complete by 31 December 2014 with expected commercial launch of the IONA® test to commence January 2015. time will tell, i hope to be out by the bods target of 50p.
when the share are consolidated,then the current price share price would be 16P,the share price would have to rise to 50p before options could be used,so we would have to go up by over %200. They have a incentive to make this work.